BeiGene | Study of BGB-11417 Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma

⟵ Back to Search Results

Study of BGB-11417 Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma

Beigene Study ID

BGB-11417-201

ClinicalTrials.gov ID

NCT05471843

EudraCT Number

2022-500687-35-00

China Drug Trials ID

CTR20221815

Sex: All

Age: 18 Years / N/A

No Study Documents

Locations

Sex: All

Age: 18 Years / N/A

No Study Documents